Published in BMC Neurosci on February 14, 2012
Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome. Brain (2014) 1.69
Pediatric Tourette syndrome: insights from recent neuroimaging studies. J Obsessive Compuls Relat Disord (2014) 0.82
Tourette syndrome and comorbid ADHD: causes and consequences. Eur J Pediatr (2014) 0.79
Association of poly(ADP-ribose) polymerase-1 polymorphism with Tourette syndrome. Neurol Sci (2013) 0.78
Effect of Deep Brain Stimulation on Regional Cerebral Blood Flow in Patients with Medically Refractory Tourette Syndrome. Front Psychiatry (2016) 0.76
Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options. World J Clin Pediatr (2016) 0.75
The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia (1971) 86.03
Voxel-based morphometry--the methods. Neuroimage (2000) 34.79
Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci (2002) 33.22
A fast diffeomorphic image registration algorithm. Neuroimage (2007) 21.56
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry (1989) 6.98
An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol (2000) 3.99
Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry (2009) 2.87
Tourette's syndrome. N Engl J Med (2001) 2.78
Course of tic severity in Tourette syndrome: the first two decades. Pediatrics (1998) 2.75
Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry (2001) 2.59
Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry (2004) 2.56
Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 2.40
A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage (2009) 2.40
Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry (2003) 2.33
Recent advances in Tourette syndrome research. Trends Neurosci (2006) 2.13
Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol (2008) 2.11
Tourette syndrome, associated conditions and the complexities of treatment. Brain (2000) 2.09
Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain (2006) 1.81
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry (1999) 1.72
Increased midbrain gray matter in Tourette's syndrome. Ann Neurol (2006) 1.69
Just pretty pictures? What diffusion tractography can add in clinical neuroscience. Curr Opin Neurol (2006) 1.60
Ten simple rules for reporting voxel-based morphometry studies. Neuroimage (2008) 1.57
Magnetic resonance-based morphometry: a window into structural plasticity of the brain. Curr Opin Neurol (2006) 1.55
Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry (2008) 1.55
Abnormal metabolic brain networks in Tourette syndrome. Neurology (2011) 1.54
The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain (2008) 1.52
Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci (2008) 1.39
Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci (2008) 1.38
Tourette's syndrome: from behaviour to biology. Lancet Neurol (2005) 1.36
Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.35
Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol (1983) 1.34
Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J Neurosci (2009) 1.33
Altered interhemispheric connectivity in individuals with Tourette's disorder. Am J Psychiatry (2004) 1.31
Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis. BMC Psychiatry (2008) 1.30
Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci (2009) 1.26
Neuroimaging of developmental psychopathologies: the importance of self-regulatory and neuroplastic processes in adolescence. Ann N Y Acad Sci (2004) 1.25
Reduced white matter connectivity in the corpus callosum of children with Tourette syndrome. J Child Psychol Psychiatry (2006) 1.16
Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res (2009) 1.16
Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry (2007) 1.14
Computational morphometry for detecting changes in brain structure due to development, aging, learning, disease and evolution. Front Neuroinform (2009) 1.13
[Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]. Nervenarzt (2003) 1.12
Selection of the control group for VBM analysis: influence of covariates, matching and sample size. Neuroimage (2008) 1.09
Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain (2010) 1.09
Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. Am J Psychiatry (2010) 1.08
Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology (2007) 1.07
Developmental processes and brain imaging studies in Tourette syndrome. J Psychosom Res (2003) 1.07
New insights into attention-deficit/hyperactivity disorder using structural neuroimaging. Curr Psychiatry Rep (2009) 1.06
Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry (2006) 1.04
Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain (2009) 1.02
The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology (2002) 1.02
Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J Korean Med Sci (2008) 1.00
Insula and striatum mediate the default bias. J Neurosci (2010) 0.99
Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am J Psychiatry (2004) 0.98
Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Am (1999) 0.96
Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res (2008) 0.95
Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord (1999) 0.93
Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry (2009) 0.91
Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences? Psychiatry Res (2001) 0.91
Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects. J Abnorm Child Psychol (2006) 0.90
Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder. J Psychiatry Neurosci (2008) 0.88
Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome. Brain Topogr (2009) 0.88
Interhemispheric connectivity and executive functioning in adults with Tourette syndrome. Neuropsychology (2006) 0.86
Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. J Psychiatry Neurosci (2010) 0.86
Increased putamen and callosal motor subregion in treatment-naïve boys with Tourette syndrome indicates changes in the bihemispheric motor network. J Child Psychol Psychiatry (2010) 0.84
Performance on Wechsler intelligence scales in children with Tourette syndrome. Eur J Paediatr Neurol (2010) 0.76
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Shared networks for auditory and motor processing in professional pianists: evidence from fMRI conjunction. Neuroimage (2005) 2.11
Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol (2009) 1.56
Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med (2008) 1.51
Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol (2004) 1.47
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci (2009) 1.26
ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci (2008) 1.22
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol (2006) 1.21
Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke (2011) 1.18
Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol (2008) 1.17
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage (2004) 1.15
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol (2009) 1.10
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One (2012) 1.09
Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol (2003) 1.08
The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.07
Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 1.05
Repetitive transcranial magnetic stimulation for the treatment of chronic pain - a pilot study. Eur Neurol (2002) 1.03
Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler (2007) 1.01
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin Colorectal Cancer (2002) 1.01
Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. Eur J Neurosci (2003) 1.01
Increased intracortical inhibition in middle-aged humans; a study using paired-pulse transcranial magnetic stimulation. Neurosci Lett (2002) 1.01
Functional neuroimaging at different disease stages reveals distinct phases of neuroplastic changes in amyotrophic lateral sclerosis. Hum Brain Mapp (2011) 1.01
Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res (2010) 1.00
Virtual endoscopy of the middle ear: experimental and clinical results of a standardised approach using multi-slice helical computed tomography. Eur Radiol (2002) 0.99
Experimental flat-panel high-spatial-resolution volume CT of the temporal bone. AJNR Am J Neuroradiol (2004) 0.99
Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2008) 0.99
Intertemporal choice in Parkinson's disease. Mov Disord (2011) 0.99
Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci (2012) 0.99
Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain (2006) 0.98
Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP. Muscle Nerve (2013) 0.97
Microstructural abnormalities of the posterior thalamic radiation and the mediodorsal thalamic nuclei in females with anorexia nervosa--a voxel based diffusion tensor imaging (DTI) study. J Psychiatr Res (2012) 0.97
Control of kinetic properties of GluR2 flop AMPA-type channels: impact of R/G nuclear editing. Eur J Neurosci (2002) 0.97
Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci (2009) 0.96
Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis (2012) 0.96
Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures. J Neural Transm (Vienna) (2015) 0.95
On emotional conflict: interference resolution of happy and angry prosody reveals valence-specific effects. Cereb Cortex (2009) 0.95
Needle acupuncture in chronic poststroke leg spasticity. Arch Phys Med Rehabil (2004) 0.94
Kinetic analysis of the agonistic and blocking properties of pentobarbital on recombinant rat alpha(1)beta(2)gamma(2S) GABA(A) receptor channels. Eur J Pharmacol (2002) 0.94
Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid Redox Signal (2012) 0.94
Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. J Psychiatr Res (2006) 0.93
Treatment of phantom limb pain with botulinum toxin type A. Pain Med (2009) 0.93
Inner ear abnormalities in patients with Goldenhar syndrome. Otol Neurotol (2005) 0.92
Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve (2011) 0.92
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging (2002) 0.92
Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2010) 0.91
Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler (2008) 0.91
Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve (2006) 0.90
Flat-panel volume computed tomography for cochlear implant electrode array examination in isolated temporal bone specimens. Otol Neurotol (2006) 0.90
Hippocampal atrophy in temporal lobe epilepsy is correlated with limbic systems atrophy. J Neurol (2005) 0.90
Sodium channel function and the excitability of human cutaneous afferents during ischaemia. J Physiol (2002) 0.89
Perception of emotional speech in Parkinson's disease. Mov Disord (2006) 0.89
Coprophenomena in Tourette syndrome. Dev Med Child Neurol (2008) 0.89
Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence. Pharmacogenet Genomics (2005) 0.89
Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathol (2012) 0.89
Rat embryonic motoneurons in long-term co-culture with Schwann cells--a system to investigate motoneuron diseases on a cellular level in vitro. J Neurosci Methods (2005) 0.89
Changes in resting-state brain networks in writer's cramp. Hum Brain Mapp (2011) 0.89
Block of voltage-operated sodium channels by 2,6-dimethylphenol, a structural analogue of lidocaine's aromatic tail. Br J Pharmacol (2002) 0.88
Increase of accuracy in intraoperative navigation through high-resolution flat-panel volume computed tomography: experimental comparison with multislice computed tomography-based navigation. Otol Neurotol (2007) 0.88
Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke (2013) 0.88
Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord (2010) 0.88
Blepharospasm: long-term treatment with either Botox®, Xeomin® or Dysport®. J Neural Transm (Vienna) (2014) 0.88
Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J Neuropathol Exp Neurol (2012) 0.87
Disturbed egocentric space representation in cervical dystonia. Mov Disord (2005) 0.87
Effect of the arterial input function on the measured perfusion values and infarct volumetric in acute cerebral ischemia evaluated by perfusion computed tomography. Invest Radiol (2007) 0.87
Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J (2009) 0.86
Structural brain abnormalities in cervical dystonia. BMC Neurosci (2013) 0.86
Cortical processing of swallowing in ALS patients with progressive dysphagia--a magnetoencephalographic study. PLoS One (2011) 0.86
Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab (2011) 0.86
Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord (2008) 0.86
Fracture of the occipital condyle caused by minor trauma in child. J Pediatr Surg (2006) 0.86
Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia. Muscle Nerve (2013) 0.85
Temporal feature perception in cochlear implant users. PLoS One (2012) 0.85
Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 0.85
Emotional speech in Parkinson's disease. Mov Disord (2008) 0.85
Educational campaign on stroke in an urban population in Northern Germany: influence on public stroke awareness and knowledge. Int J Stroke (2012) 0.85
Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis. J Neurol (2014) 0.85
A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function. BMC Neurosci (2011) 0.85
Thermal effects in high average power optical parametric amplifiers. Opt Lett (2013) 0.84
Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms. BMC Neurosci (2014) 0.84
Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V. J Physiol (2003) 0.84
Registration and fusion of CT and MRI of the temporal bone. J Comput Assist Tomogr (2005) 0.84
Changes of emotional prosody in Parkinson's disease. J Neurol Sci (2009) 0.84
Role of mitochondria in kainate-induced fast Ca2+ transients in cultured spinal motor neurons. Cell Calcium (2007) 0.84
Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons. Exp Neurol (2013) 0.84